Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates

Liver Transplantation

Volumn 13, Issue 2, 2007, Pages 206-214

  Roberts, D Neil ^a   Arguedas, Miguel R ^b,c   Fallon, Michael B ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FUROSEMIDE; NORFLOXACIN; PROPRANOLOL; SPIRONOLACTONE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; HEALTH CARE COST; HEPATOPULMONARY SYNDROME; HUMAN; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEDICARE; MONTE CARLO METHOD; ORTHOTOPIC TRANSPLANTATION; OUTCOMES RESEARCH; PATIENT SELECTION; PORTAL HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE PAYMENT; PULSE OXIMETRY; QUESTIONNAIRE; REIMBURSEMENT; SENSITIVITY ANALYSIS; SURVIVAL RATE; VALIDATION PROCESS;

COST-BENEFIT ANALYSIS; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 33847643168     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20931     Document Type: Article

References (26)

1. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463-472.
2. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 2002;97:2886-2895.
3. Gines P, Qientero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-128.
4. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125:1042-1052.
5. Swanson K, Wiesner R, Krowka M. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005;41:1122-1129.
6. Arguedas M, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-197.
7. Sonnenberg F, Beck J. Markov models in medical decision making: a practical guide. Med Decis Making 1993:322-338.
8. Mahler D, Weinberg D, Wells C, Feinstein A. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-758.
9. Sood G, Fallon MB, Niwas S, Tutton T, van Leeuwen DJ, Bloomer JR, et al. Utility of a dyspnea-fatigue index for screening liver transplant candidates for hepatopulmonary syndrome [abstract]. Hepatology 1998;28:2319.
10. Centers for Disease Control and Prevention, National Vital Statistics Reports. United States life Tables. Natl Vital Stat Rep 1999;47:1-33.
11. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, on behalf of the ERS Task Force Pulmonary-Hepatic Vascular Disorders Scientific Committee ERS Task Force PHD Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004;24:861-880.
12. United Network for Organ Sharing: 2006. Available at http://www.unos.org. Accessed: February 9, 2006.
13. Lipscomb J, Weinstein M, Torrance G. Time preference. In: Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:214-246.
14. Davis G, Albright J, Cook S, Rosenberg D. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-338.
15. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-1288.
16. Abrams GA, Sanders MK, Fallon MB. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002;8:391-396.
17. Martinez G, Barbera J, Visa J, Rimola A, Parc J, Roca J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:756-758.
18. Whyte M, Hughes J, Peters A. Ussov W, Patel S, Burroughs A. Analysis of intrapulmonary right to left shunt in hepatopulmonary syndrome. J Hepatol 1998;29:85-93.
19. 2 response to 100% oxygen, and brain uptake after 99mTc MAA lung scanning. Chest 2000; 118:615-624.
20. Drug Topics Red Book. Montvale, NJ: Medical Economics Company; 2002.
21. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004;53:744-749.
22. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:651-657.
23. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Muller C. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-859.
24. Krowka MJ, Mandell S, Ramsay MA, Kawut S, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174-182.
25. Taille C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003;79:1482-1489.
26. Planas R, Balleste B, Alvarez M, Rivera M, Montoliu S, Galeras J, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004;40:823-830.